TO STUDY THE EFFECT OF DWIHARIDRADI LOHAM AND FERROUS SULPHATE ON PANDU

A STANDARD CONTROLLED CLINICAL TRIAL OF DWIHARIDRADI LOHAM IN THE MANAGEMENT OF PANDU WITH SPECIAL REFERENCE TO IRON DEFICIENCY ANAEMIA

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/08/015511

Enrollment

Registered

2018-08-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D599- Acquired hemolytic anemia, unspecified

Interventions

Intervention1: NIL: NIL Control Intervention1: DWIHARIDRADI LOHAM: DWIHARIDRADI LOHAM 500 MG TWICE A DAY FOR 2 MONTHS Control Intervention2: FERROUS SULPHATE: FERROUS SULPHATE 200 MG ONCE A DAY FOR 2

Eligibility

Inclusion criteria

Inclusion criteria: All types of Pandu Vyadhi Except Mrudbhakshanjanya Pandu as per described in Ayurvedic samhita

Exclusion criteria

Exclusion criteria: 1.Aneamia associated with other diseases like liver cirrhosis, ascitis, CCF, alcoholic liver diseases, HIV etc. 2. Patients suffering from other than iron deficiency anaemia ï?· 3.Patients with complication of Iron deficiency anaemia ï?· 4.Any type of malignant diseases ï?· ï?· 5.Acute Heamorrhagical and infectious condition ï?·6.Patient taking treatment from any other pathy for the same problem.

Design outcomes

Primary

Measure	Time frame
To Reduce Sign and Symptoms of Pandu As Following 1. Panduta (Pallor) 2. Aayasenshwas (Dyspnoea On Exertion) 3. AkshikootShotha (Periorbital Oedema) 4. Agni Mandya (Anorexia) 5. Dourbalya (Weakness) 6.CBC PROFILETimepoint: 2 MONTHS	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDRSNEHAL BABURAO BHOSALE

COLLEGE OF AYURVEDA AND RESAEARCH CENTRE NIGADI PUNE

medhamaheshjoshi@gmail.com9881465798

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026